Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is one of the 20 Best Performing Stocks in 2025. Needham analyst Ami Fadia
Turning 65 means you qualify for Medicare, but is it cheaper? Medicare Part B premiums are $202.90 monthly, up from
CEO Scott Keeney of nLIGHT (NASDAQ: LASR) sold 31,748 shares on Jan. 6, 2026, for approximately $1.19 million, representing 1.37%
The Medicare Advantage Open Enrollment Period for 2026 is from Jan. 1 to March 31, only for those already on
CATL has opened the Middle East’s largest new energy aftermarket facility in Riyadh, supporting the region’s transition to cleaner energy.
At present, there are 11 public companies valued at over $1 trillion, with 9 of them operating in the tech
Arrowhead Pharmaceuticals CEO Christopher Anzalone sold 85,000 shares in the open market on Dec. 17, 2025, totaling approximately $5,443,462. This
Social Security is a crucial source of income for many retirees, with 62% relying on it. Changes in 2026 will
Chief Legal Officer David Kuo of Applied Optoelectronics sold 12,500 shares for $501,875 on Dec. 23, 2025, reducing direct ownership
In 2025, XRP received significant upgrades and Ripple made key acquisitions, setting the stage for 2026. The launch of the
CEO Mark Dankberg of Viasat sold 100,000 shares indirectly for $4.0 million on Jan. 6, 2026, reducing his indirect holdings
Nvidia unveils its next-generation AI superchip platform as demand for Blackwell chips remains high. CEO Jensen Huang expresses admiration for
The semiconductor industry is nearing $1 trillion in annual sales, sparking interest from stock market investors seeking the best stocks
NuScale Power may be a valuable energy source for tech giants eyeing nuclear energy advancements, but it is not yet
The Vanguard Dividend Appreciation ETF (VIG) has shown stronger recent returns and boasts a larger, more diversified portfolio compared to
To claim the maximum Social Security benefit of $5,251, you need to have worked for at least 35 years and
Cardano price is down 2% over the past 24 hours, trending lower since January 6, but remains flat over the
The FlexShares Global Quality Real Estate Index Fund (GQRE) and iShares Global REIT ETF (REET) offer exposure to global real
Meta Platforms (META) faces a delay in the international rollout of its Ray-Ban Display smart glasses due to high demand
The iShares Semiconductor ETF (SOXX) and State Street Technology Select Sector SPDR ETF (XLK) offer different levels of sector focus
Teva Pharmaceutical Industries Limited (NYSE: TEVA) has been identified as one of the best performing pharma stocks in 2025. Truist
Amneal Pharmaceuticals, Inc. (AMRX) is among the best performing pharma stocks in 2025, with Truist raising its price target to
Eli Lilly and Company (NYSE:LLY) is acquiring Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on oral therapies for inflammatory
Indivior PLC (NASDAQ:INDV) is among the best performing pharma stocks in 2025, with a full-year 2026 financial guidance predicting total
Amarin Corporation plc (NASDAQ: AMRN) is one of the best performing pharma stocks in 2025, achieving positive cash flow in
